HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tapson, V. F. Articles by Humbert, M. Search for Related Content PubMed PubMed Citation Articles by Tapson, V. F. Articles by Humbert, M.

Incidence and Prevalence of Chronic Thromboembolic Pulmonary Hypertension

From Acute to Chronic Pulmonary Embolism

Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina; and Department of Respiratory Medicine, Hospital Antoine Béclère, Clamart, France

Correspondence and requests for reprints should be addressed to Victor F. Tapson, M.D., Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710. E-mail: tapso001{at}mc.duke.edu

ABSTRACT

The incidence and prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) are yet to be accurately determined and may be significantly underestimated. Historically, the occurrence of CTEPH in patients diagnosed with acute pulmonary embolism (PE) has been considered rare. Data from autopsy studies estimated the incidence of CTEPH at 1–3% overall and at 0.1–0.5% in patients surviving acute PE. Data indicate that each year in the United States, approximately 600,000 individuals suffer an acute pulmonary embolic event and that the annual number of new CTEPH cases in the United States is between 500 and 2,500. This may underestimate the true frequency of CTEPH because the disease is often misdiagnosed due to nonspecific symptoms and variable disease course. A monocenter, prospective, longitudinal study assessing symptomatic CTEPH in patients with acute PE but without prior venous thromboembolism recently estimated the cumulative incidence of CTEPH to be 1.0% 6 mo after PE, 3.1% after 1 yr, and 3.8% after 2 yr; overall post-PE incidence was approximately 3%. Further studies are needed to better define the true rate of CTEPH. Acute embolic events can occur without symptoms, and symptomatic PE is often overlooked or misdiagnosed in practice. CTEPH is often identified during diagnostic work-up in patients with unexplained pulmonary hypertension, many of whom lack medical history suggesting previous PE. In a recent study in 142 consecutive patients with CTEPH, 90 (63%) had no previous history of symptomatic venous thromboembolism. Further prospective epidemiologic studies are needed to better define the incidence and prevalence of CTEPH.

Key Words: deep vein thrombosis • pulmonary embolism • pulmonary hypertension • thromboembolism • venous thromboembolism

This article has been cited by other articles:

				M. Toshner, J. Suntharalingam, K. Goldsmith, A. Niggebrugge, J. Pepke-Zaba, N. W. Morrell, S. Tsui, J. Flowers, and D. Jenkins Current differences in referral patterns for pulmonary endarterectomy in the UK Eur. Respir. J., September 1, 2008; 32(3): 660 - 663. [Abstract] [Full Text] [PDF]

				M. Lankeit, C. Dellas, A. Panzenbock, N. Skoro-Sajer, D. Bonderman, M. Olschewski, K. Schafer, M. Puls, S. Konstantinides, and I. M. Lang Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension Eur. Respir. J., May 1, 2008; 31(5): 1024 - 1029. [Abstract] [Full Text] [PDF]

				L. J. Rubin, M. M. Hoeper, W. Klepetko, N. Galie, I. M. Lang, and G. Simonneau Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses Proceedings of the ATS, September 1, 2006; 3(7): 601 - 607. [Abstract] [Full Text] [PDF]